24 results
8-K
EX-10.1
GOSS
Gossamer Bio Inc
20 Jul 23
Gossamer Bio Announces $212 Million Private Placement Financing
4:01pm
conditions of approval and policies imposed by any institutional review board, ethics review board or committee responsible for the oversight
PRE 14A
GOSS
Gossamer Bio Inc
17 Apr 23
Preliminary proxy
4:01pm
;
reviewing and approving any related party transactions and reviewing and monitoring compliance with our code of conduct and ethics; and
reviewing … , appointing) such candidates, will take into account many factors, including the following:
personal and professional integrity, ethics and values
424B5
bxg9tsrn452 ch40nz
19 May 20
Prospectus supplement for primary offering
5:11pm
424B5
mpxib94 ht9
19 May 20
Prospectus supplement for primary offering
5:08pm
424B5
zr9tgnhe 5klctz7tsr6
18 May 20
Prospectus supplement for primary offering
4:16pm
424B5
qqlgq 77rafj06ukeu
18 May 20
Prospectus supplement for primary offering
4:11pm
DEF 14A
x7xyo
30 Apr 19
Definitive proxy
4:04pm
10-K
t3r0478n2va241g0p
22 Mar 19
Annual report
4:45pm
424B4
rayol563xjs7e278qu7
8 Feb 19
Prospectus supplement with pricing info
4:40pm